Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

AKN-028 significantly alters gene expression profiles of AML cells

Dec. 29, 2010

PI3K-alpha inhibitor PIK-75 induces apoptosis of AML cells

Dec. 29, 2010

Interim analysis of SENSE trial data shows superior safety of etravirine vs. efavirenz in HIV

Dec. 29, 2010

ODE-(S)-HPMPA and ODE-(S)-HPMPC inhibit HIV replication by new mode of action

Dec. 29, 2010

Gel formulation of IQP-0528 plus tenofovir evaluated in vitro as HIV therapy

Dec. 28, 2010

New CREB-1 inhibitor XX-650-23 shows promise to treat AML

Dec. 28, 2010

In vitro data support potential benefits of TT-30 in complement-mediated diseases

Dec. 28, 2010

Asymmetrical CADA analogue VGD-020 displays improved potency against CD4

Dec. 28, 2010

HDAC inhibitor PCI-24781 displays in vivo anti-inflammatory effects

Dec. 27, 2010

Cyclacel's cell cycle inhibitor CYC-065 suppresses growth of MM cell in vitro

Dec. 27, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...